New Drug Data Alert - Atogepant
from HeadWise
New data was revealed this month on the upcoming gepant indicated for migraine prevention called Atogepant. Dr. Lindsay Weitzel questions Dr. Tim Smith about its safety and effectiveness. How will we take it and how often? Also, when will it be available?
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of HeadWise?
This episode is 16 minutes long.
When was this HeadWise episode published?
This episode was published on August 13, 2020.
Can I download this HeadWise episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.